Drug Trial Radar · NCT07382661
Drug-Drug Interaction Between DW4421 and Amoxicillin/Clarithromycin
Last checked: Nov 20, 2026Latest source record: Feb 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
36
Planned (sponsor's estimate)
Start
Feb 2026
Primary completion
May 2026
Study completion Oct 2026
Sponsor
- Lead sponsor
- Daewon Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Feb 3, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated drug
- No
- Who can join
- All sexes, from 19 years, up to 50 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Drug-Drug Interaction between DW4421 and Amoxicillin/Clarithromycin
Conditions
- Healthy Adult Volunteers
Interventions
DW4421Drug
1 tablet will be orally administered
DW4421-1Drug
2 capsules will be orally administered
DW4421-2Drug
1 tablet will be orally administered
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cmax,ss: Maximum concentration of DW4421, DW4421-1 and DW4421-2 at steady stateTime frame: Up to day 6 or day 7
- AUCτ,ss: Area under the drug concentration-time curve of DW4421, DW4421-1, DW4421-2 within a dosing interval at steady stateTime frame: Up to day 6 or day 7
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Chungbuk National University Hospital
Cheongju-si, North Chungcheong, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.